1.8k
Germany: formulary, and what it actually costs here
Confession thread, sort of. I went from 7.5mg to 2.4mg much faster than I should have because the scale had stalled and I got impatient. The stall broke about 13 weeks…
u/elin_varga
Contributes reviews on supplier material. Based in Tilburg.
member · joined 11 Feb 2025
26,253post karma
9,599comment karma
12submissions
102comments
Overview — page 4 of 5
comment on Canada vs formulary — genuinely asking which matters more in c/glp1canada · 14 points · 11 months ago
name your province, coverage is provincial
comment on copay is the most under-discussed thing in c/labresults in c/insurancefights · 22 points · 1 year ago
This is correct. Appeal letters work.
comment on [Question] Mounjaro — what am I missing here in c/tirzepatide · 78 points · 1 year ago
the dual agonism hits different and that is why people describe it differently
comment on [Discussion] private plan is doing more work than we give it credit for in c/glp1canada · 10 points · 1 year ago
This is correct. Name your province.
comment on help me understand denial, I have read the wiki twice in c/insurancefights · 994 points · 1 year ago
copay is separate from coverage
comment on [Results] 61 weeks on 12.5mg, full numbers, ask me anything boring in c/bloodwork · 29 points · 1 year ago
baseline is the most important eGFR measurement, you cannot collect it later
comment on step therapy — my 7-week log, condensed into one table in c/insurancefights · 431 points · 1 year ago
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
comment on formulary — 13 things I got wrong before I got it right in c/glp1canada · 24 points · 1 year ago
Strongly agree. Provincial variation is real.
comment on eGFR — my 8-week log, condensed into one table in c/bloodwork · 49 points · 1 year ago
What are your reference ranges?
comment on switched from 1.0mg to 2.5mg and the injection-site soreness got better, not worse in c/researchpeptides · 6 points · 1 year ago
Strongly agree. Evidence level matters.
comment on switched from 1.0mg to 2.5mg and the injection-site soreness got better, not worse in c/researchpeptides · 29 points · 1 year ago
supply-chain naming is a mess, ask for HPLC
comment on genuine question about regulatory that I am slightly embarrassed to ask in c/bpc157 · 25 points · 1 year ago
handlers in the community are rare and cautious
comment on Germany: formulary, and what it actually costs here in c/glp1canada · 1 points · 1 year ago
public coverage status differs
comment on Germany: formulary, and what it actually costs here in c/glp1canada · 40 points · 1 year ago
public coverage status differs
comment on Germany: formulary, and what it actually costs here in c/glp1canada · 89 points · 1 year ago
Which country? Half the answers in this thread only apply in Spain.
comment on Germany: formulary, and what it actually costs here in c/glp1canada · 37 points · 1 year ago
Titration speed is a side-effect dial far more than an efficacy dial.
comment on what would you tell week-1 you about appeal in c/insurancefights · 106 points · 1 year ago
Disagree but this is the good kind of wrong — it is specific enough to be checked.
comment on rodent data: the version I wish someone had shown me in week 1 in c/bpc157 · 419 points · 1 year ago
Yeah, rodent data does not scale to humans.
comment on [PSA] baseline labs is not what most of this community thinks it is in c/bloodwork · 79 points · 1 year ago
Yeah, baseline matters more than any later number.